The Sympathetic Nervous System is made up of noradrenergic neurons which release norepinephrine.
This hypothesis suggests ME comprises three subtypes- one involving norepinephrine deficiency & two involving reduced expression of the norepinephrine transporter.
In Subtype 3 (ME3) There is a deficiency of norepinephrine synthesis, worsened by mental & physical exertion. Causes could be BH4 deficiency, reduced tyrosine hydroxylase activity or other factors.
The NIH Intramural ME study indicated a norepinephrine and dopamine deficiency, in particular DOPAC & DHPG were low. As DHPG is made from the break down of norepinephrine INSIDE the neuron, low DHPG could indicate low norepinephrine inside the neuron. If this is caused by a synthesis problem in the ME3 Subtype, what's causing this in the ME1 & ME2 subtypes?
ME1 & ME2 could have reduced norepinephrine transporter (NET) on neurons, reducing the reuptake of norepinephrine into the neuron, leading to high levels of extracellular norepinephrine. This could be caused by high insulin levels, as insulin receptors can control norepinephrine transporter expression.
A genetic study by PrecisionLife found insulin secretion gene variants are a risk factor for a subset of MECFS patients. They found the insulin receptor gene to be relevant in both ME & Long Covid.
The ME1 subtype could be caused by a high & fast insulin release and/or hypersensitive insulin receptors. The ME2 subtype could be caused by prolonged insulin secretion from the pancreas
The prolonged insulin release in ME2 may lead to development of insulin resistance. A recent study of molecular and cellular blood traits found evidence of insulin resistance and liver disease.
Insulin resistance may be the cause of microclots in ME & Long COVID as insulin resistant platelets become hyperactivated which could lead to microclot formation. ME2 patients may benefit from taking nattokinase.
High extracellular norepinephrine could cause downregulation of beta adrenergic receptors. Testosterone prevents this, and means that receptor downregulation might not be happening in most male patients.
Why would insulin not cause a problem earlier in life? As cortisol can increase insulin receptor resistance, cortisol may have masked the problem, until the development of glucocorticoid receptor resistance or low cortisol increases neuronal sensitivity to insulin.
The final trigger of a virus, concussion or vaccine can all increase glucose levels. Hyperglycemia and insulin resistance has been found at least 2 months after SARS-CoV-2 infection.
Combined with increased insulin secretion and high insulin receptor sensitivity, this leads to the norepinephrine transporter becoming downregulated and leads to increased SNS activation and activation of noradrenergic pathways in the brain.